Please ensure Javascript is enabled for purposes of website accessibility

pharmaceuticals

Richmond pharma company Kaléo acquired
Nov 29, 2021

Richmond pharma company Kaléo acquired

New York-based Marathon Asset Management LP announced Monday it has entered into a definitive agreement to acquire Richmond-based privately held pharmaceutical company Kaléo Inc., which is known for making injectors to treat allergic anaphylaxis and opioids overdoses. The total base purchase price is approximately $310 million in cash, less certain adjustments and includes potential net […[...]

Aug 29, 2021

Health care

NANCY HOWELL AGEE PRESIDENT AND CEO, CARILION CLINIC, ROANOKE Agee leads Carilion Clinic, a nonprofit integrated health system that serves more than 1 million people in Virginia and West Virginia and is the Roanoke Valley’s largest employer. Agee began her career in health care as a nurse, then moved into leadership roles at Carilion. As […]

Combating the opioid crisis
Jul 21, 2021

Virginia could receive $530M from $26B opioids settlement

Virginia is expected to receive about $530 million as part of a $26 billion settlement that the nation’s three primary drug distributors and pharmaceutical manufacturer Johnson & Johnson reached Wednesday with the states that would release the companies from legal liability in the opioid crisis. A majority of the roughly $530 million that Virginia is expected […]

May 4, 2021

AMPAC expanding Petersburg operation, adding 156 jobs

AMPAC Fine Chemicals plans to grow its Petersburg manufacturing facility, investing $25 million and creating 156 jobs, Gov. Ralph Northam announced Tuesday. AMPAC manufactures active pharmaceutical ingredients (APIs) and is a partner with Richmond-based Phlow Corp., Virginia Commonwealth University’s Medicines for All Institute and nonprofit drugmaker Civica Inc., on a federally funded, $354[...]

Apr 20, 2021

Central Va. pharma hub strategic plan released

On Tuesday, the Virginia Commonwealth University College of Engineering announced its strategy to turn Central Virginia into an advanced pharmaceutical manufacturing, research and development hub. The strategic plan aims to foster business and job growth in the Richmond-Petersburg area while also expanding access to medicines. The creation of the plan was funded by a $100,000 […]

Mar 3, 2021

Prince William company to expand manufacturing of COVID-19 test products

Prince William County-based Ceres Nanosciences Inc. will increase manufacturing of its reagent product used in COVID-19 tests, Gov. Ralph Northam announced Wednesday. The project will create 50 jobs in engineering, advanced manufacturing and materials science during the next three years. “This expansion will enable Ceres Nanosciences to vastly increase production of its patented technology to [&[...]

Feb 4, 2021

New drug cocktail appears to block COVID among people exposed to virus

The University of Virginia Health System is testing an antibody cocktail that so far has blocked 100% of symptomatic COVID-19 cases among people who were exposed to the coronavirus, U.Va. Health announced this week. New York-based Regeneron Pharmaceuticals produces the treatment, which is being tested at several facilities, and also has proven to be effective […]

Feb 1, 2021

Pharma manufacturer announces Albemarle County expansion

Pharmaceutical manufacturer Afton Scientific LLC will invest $500,000 to expand its Albemarle County operations, adding 20 jobs, Gov. Ralph Northam announced Monday. The company will add 8,000 square feet to its 2020 Avon Court facility to “accommodate its 50% growth over the past year and expected similar growth in 2021,” according to a statement from […]

Dec 23, 2020

Richmond pharma company makes leadership appointments

Richmond-based pharmaceutical company Kaléo announced Tuesday five executive leadership appointments and promotions. Joining Kaléo from Boston Scientific, where he served as the senior vice president of corporate compliance and privacy officer, Kevin Espinoza has been hired as chief compliance officer. He will oversee Kaléo’s operations. He has also previously worked with Forest Laborator[...]

Jul 24, 2020

Chesterfield pharma company enters $600M federal plea deal

Less than one month after former Indivior PLC CEO Shaun Thaxter pleaded guilty in federal court in Abingdon to a misdemeanor criminal charge related to the marketing of the Chesterfield County-based company’s opioid addiction treatment drug Suboxone, the company announced Friday it has entered a $600 million plea deal with the U.S. Justice Department, the […]

Jun 30, 2020

Ex Chesterfield pharma CEO pleads guilty in federal opioid treatment investigation

Shaun Thaxter, former CEO of Chesterfield County-based pharmaceutical manufacturer Indivior PLC, pleaded guilty Tuesday in federal court in Abingdon to a misdemeanor criminal charge related to the U.S Justice Department’s probe into the marketing of Suboxone, Indivior’s opioid addiction treatment drug. Thaxter pleaded guilty to one count of violating the Federal Food, Drug, and Cosmeti[...]

Dr. Eric Edwards
May 19, 2020

Trump administration chooses RVA pharma startup for $354M COVID-19 contract

Richmond-based drug manufacturing company Phlow Corp., which incorporated this year, announced Tuesday that the Trump administration has awarded it a $354 million, four-year contract to manufacture in the U.S. generic medicines and pharmaceutical ingredients needed to treat COVID-19, creating an American supply chain for medical products that are now made mostly in China and India.  […]

YOUR NEWS.
YOUR INBOX.
DAILY.

By subscribing you agree to our Privacy Policy.